Dexcom - Latest News and Information
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
DXCM
Dexcom is a global medical device company specializing in continuous glucose monitoring (CGM) technology for diabetes management. It develops and markets CGM systems that provide real-time glucose readings and data to phones or receivers, enabling users to monitor glucose levels and make informed health decisions. The company has a long history in glucose biosensing and supports an ecosystem of connected partners, with products like Dexcom G7 and Stelo Glucose Biosensor, and operates worldwide from its base in San Diego, California. Since its founding in 1999, Dexcom has focused on improving diabetes care by delivering accurate, non-invasive or minimally invasive glucose monitoring solutions.
Health Recovery Solutions (HRS) Acquires Rimidi for Chronic Care Management and RPM Integration
Stocks Making the Biggest Moves Midday: Moderna, Instacart, Rivian Automotive, DraftKings, Coinbase & More
GlucoTrack Shares Jump 34% as FDA IDE Submission Looms for Implantable Glucose Monitor
Dexcom Seeks Expanded Medicare Coverage of CGMs for Type 2 Diabetes
US Stocks Today | Big Tech Stocks Lose Billions as AI Spending Fears Hit Valuations
Multiple CGM Sensors May Be Used with Automated Insulin Delivery
AI Nutrition Tracking Stinks
Market Quote of the Day by Sir John Templeton | “The Time of Maximum Pessimism Is the Best Time to Buy”
No recent deals for this company.
